Skip to content

Clinical trials

Phase 1/2 Triple Negative Breast Neoplasms trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Phase: Phase 1/2 Country / region: Spain Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20162
20174
20184
20191
20206
20212
20224
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting8
Terminated5
Active, not recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb4
BicycleTx Limited2
Cantargia AB2
Genmab2
Novartis Pharmaceuticals2
Amgen1
BioAtla, Inc.1
Eisai Inc.1
Fundacio Clinic Barcelona1
Fundacion Oncosur1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms28
Carcinoma, Non-Small-Cell Lung17
Ovarian Neoplasms10
Squamous Cell Carcinoma of Head and Neck10
Melanoma9
Colorectal Neoplasms8
Neoplasm Metastasis7
Breast Neoplasms6
Carcinoma, Renal Cell6
Endometrial Neoplasms6

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.